WALTHAM, Mass. — Thermo Fisher Scientific has introduced its latest advancement in cellular analysis with the launch of the Invitrogen™ Attune™ Xenith™ Flow Cytometer, a spectral-enabled system designed to deliver faster, more versatile, and more reliable results for immunology and immuno-oncology researchers.
Built on Thermo Fisher’s acoustic focusing technology, the new flow cytometer enhances time to results while allowing scientists to extract deeper cellular insights using minimal sample volumes. The system is engineered to support both spectral unmixing and conventional flow cytometry, expanding the scope of research applications it can accommodate with high flexibility and sensitivity.
As scientific research into complex diseases like cancer demands increasingly detailed cellular data, traditional cytometry instruments often fall short due to issues such as difficult-to-use software, frequent clogs, and inefficient data processing. The Attune Xenith addresses these concerns with intuitive software, advanced diagnostic tools, and robust hardware capable of high-speed, high-resolution analysis. It incorporates six lasers and 51 fluorescent detectors, enabling in-depth analysis across multiple parameters, while its clog-resistant design and automated maintenance systems help maintain extended uptime and reduce sample waste.
Trisha Dowling, vice president of flow and imaging technologies at Thermo Fisher Scientific, emphasized the impact the instrument will have in the lab. “We’re thrilled to provide a solution that enhances both speed and accuracy in cellular analysis,” she said. “The Attune Xenith Flow Cytometer empowers researchers to analyze more samples with greater precision, accelerating the pace of scientific discovery.”
The system is already in use at Amsterdam UMC, where Dr. Juan J. Garcia Vallejo, associate professor of molecular cell biology and immunology, praised its performance. “The Attune Xenith is a robust and powerful instrument,” he said. “It allows our users to easily set up assays in either conventional or spectral mode, combining flexibility with the high-speed acoustics and reliability the Attune line is known for.”
The new flow cytometer joins Thermo Fisher’s existing portfolio, which includes the Attune CytPix and NxT instruments, and further demonstrates the company’s commitment to equipping researchers with tools that improve efficiency, enhance data quality, and support groundbreaking discoveries in biomedical science.
